Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Utrecht
SEC filing record 1 source field available
Fiscal year end
31 December
LAVA Therapeutics NV has filed 169 SEC EDGAR filings since 25 Jan 2021

SEC filing history

Showing 1-25 of 30 matching filings.

Per page
25
Current page
1
6-K File 001-40241

6-K

Filing date
10 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
20 Aug 2024
Reporting date
20 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
20 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
06 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
21 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
21 Mar 2024
Reporting date
20 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
16 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
22 Aug 2023
Reporting date
22 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
15 Aug 2023
Reporting date
15 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
15 Jun 2023
Reporting date
15 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
08 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
24 Apr 2023
Reporting date
24 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
12 Apr 2023
Reporting date
12 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
13 Mar 2023
Reporting date
13 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
16 Feb 2023
Reporting date
16 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
06 Feb 2023
Reporting date
06 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
06 Jan 2023
Reporting date
06 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
16 Nov 2022
Reporting date
16 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
30 Sep 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
13 Sep 2022
Reporting date
13 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
15 Jun 2022
Reporting date
15 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
02 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40241

6-K

Filing date
28 Mar 2022
Reporting date
28 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .